Company Filing History:
Years Active: 2022
Title: Lihu Yang - Innovator in Selective A2A Receptor Antagonism
Introduction
Lihu Yang is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmacology, particularly through his work on selective A2A receptor antagonists. His innovative approach has the potential to impact the treatment of various diseases.
Latest Patents
Lihu Yang holds 1 patent for his invention titled "Selective A2A receptor antagonist." This patent relates to a selective A receptor antagonist, specifically one defined by Formula (I). The invention includes a pharmaceutical composition comprising the antagonist and its use in manufacturing a medicament for treating diseases.
Career Highlights
Lihu Yang is associated with Inxmed (Nanjing) Co., Ltd., where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and improving therapeutic options for patients.
Collaborations
Lihu Yang collaborates with Zaiqi Wang, contributing to a dynamic research environment that fosters creativity and scientific advancement.
Conclusion
Lihu Yang's contributions to the field of selective A2A receptor antagonism exemplify the spirit of innovation in modern medicine. His work not only enhances our understanding of pharmacological treatments but also paves the way for future advancements in healthcare.